Your browser doesn't support javascript.
loading
The Non-Aromatic Δ5-Androstenediol Derivative of Dehydroepiandrosterone Acts as an Estrogen Agonist in Neonatal Rat Osteoblasts through an Estrogen Receptor α-related Mechanism.
Langley, Elizabeth; Velazquez-Cruz, Rafael; Parra-Torres, Alma; Enríquez, Juana.
Afiliação
  • Langley E; a Departamento de Investigación Básica , Instituto Nacional de Cancerología , Mexico City , Mexico.
  • Velazquez-Cruz R; b Laboratorio de Genómica del Metabolismo Óseo , Instituto Nacional de Medicina Genómica , Mexico City , Mexico.
  • Parra-Torres A; b Laboratorio de Genómica del Metabolismo Óseo , Instituto Nacional de Medicina Genómica , Mexico City , Mexico.
  • Enríquez J; c Departamento de Biología de la Reproducción Carlos Gual Castro , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) , Mexico City , Mexico.
Endocr Res ; 44(3): 87-102, 2019 Aug.
Article em En | MEDLINE | ID: mdl-30580653
Purpose: It has been proposed that DHEA influences bone formation through, bioconversion to 17ß-estradiol; however, DHEA is converted to Δ5-androstenediol (Δ5-Adiol), a metabolite with estrogenic potential involved in diverse biological process. To gain new insight into the role of Δ5-Adiol in bone cells, we examined DHEA and Δ5-Adiol effects in neonatal rat and human hFOB1.19 osteoblasts. Methods: Osteoblast activity was assessed by analyzing proliferation, alkaline phosphatase activity, and expression of OSX and ALPL. We also examined binding affinities for osteoblast-ER and transcriptional activation of human (h)ERα, hERß or hAR in U2-OS cells. Results: The most striking finding was that Δ5-Adiol had greater stimulatory effect than DHEA on rat osteoblast proliferation and differentiation, as well as ALPL expression in human osteoblasts. Interestingly, the Δ5-Adiol or DHEA-induced effects were not precluded with letrozole or trilostane, consistent with bioconversion of DHEA to Δ5-Adiol due to elevated expression of Hsd17b1 in neonatal rat osteoblasts, suggesting a high level of 17ß-hydroxysteroid dehydrogenase type 1 activity. Conversely, Δ5-Adiol and DHEA-induced proliferative effects were inhibited with ICI 182780 alone or combined with trilostane, which correlates with the higher binding affinity of Δ5-Adiol for ER compared to DHEA. Furthermore, Δ5-Adiol showed a greater relative agonist activity for hERα than for hERß or hAR. Conclusion: This study is the first to show that a bioactive DHEA derivative stimulates E2-dependent osteoblast activities, including proliferation and differentiation in rat and human osteoblasts, through ERα-related mechanisms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoblastos / Desidroepiandrosterona / Receptor alfa de Estrogênio / Androstenodiol Limite: Animals / Female / Humans Idioma: En Revista: Endocr Res Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoblastos / Desidroepiandrosterona / Receptor alfa de Estrogênio / Androstenodiol Limite: Animals / Female / Humans Idioma: En Revista: Endocr Res Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido